Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
19 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

ADMA — ADMA Biologics, Inc. Dilution Risk Tracker

Track ADMA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ADMA — Get alerts when the score changes →

As of August 28, 2026, ADMA Biologics, Inc. (ADMA) has a DilutionWatch DilutionScore of 19/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. ADMA Biologics, Inc. has a market capitalization of $1.85B, 223.98M shares outstanding, 360 institutional holders tracked. Stored dilution-related fields include 966.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰Cash Runway
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ADMA.
🔔 Track ADMA — Get forecast alerts →

Market Data

Market Cap$1.85B
Shares Outstanding223.98M
Float226.73M
Cash$136.02M
Debt$196.59M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 6.8% shares (2026Q1 vs prior)
360 institutional holders · 242.43M shares
#1 BlackRock, Inc. 36.83M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 20.61M shares
#3 STATE STREET CORP 14.08M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest21.92M
Days to Cover8.8
% of Float9.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2012-12-31
Form 4 INSIDER TRANSACTION 2026-07-24
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-03-17
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ADMA Dilution Snapshot

ADMA Biologics, Inc. (ADMA) has a DilutionScore of 19/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ADMA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ADMA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for ADMA
ADMA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.